This podcast provides information regarding the New Medicine Service (NMS), an advanced service within the Community Pharmacy Contractual Framework in England aimed at improving patient adherence to newly prescribed medications for long-term conditions. Specifically, the announcements detail a significant expansion of the NMS to include depression as an eligible therapeutic area, with a provisional commencement date of October 29, 2025, according to Community Pharmacy England, though an earlier August 2025 announcement from NHSBSA suggests a publication timeline. Furthermore, the documents outline several operational updates, including amendments to the service specification and eligible drug list following a comprehensive review, and a change to the payment structure effective April 1, 2025, which simplifies compensation to £14 per consultation. Finally, the sources clarify regulatory matters, such as amended timelines for consultations and new guidance concerning the subcontracting of NMS provision.